Abstract
Ruthenium complexes that act as nitric oxide (NO) donors show potential cytotoxicity in tumor models. In this work, we proposed the synthesis of the new nitrosyl ruthenium complex trans-[Ru(NO2)(NO)(dppb)(o-bdqi)]Cl2, containing a non-innocent ligand of the o-phenylenediamine type (o-bdqi). The 31P{1H} NMR spectra confirmed that the trans-[Ru(NO2)(NO)(dppb)(o-bqdi)] is the isomer formed. The complex was characterized by elemental analysis, mass spectrometry, UV–vis and infrared spectroscopy and cyclic voltammetry. Natural transition orbitals (NTOs) for trans-[RuCl2(dppb)(o-bdqi)] and trans-[Ru(NO2)(NO)(dppb)(o-bdqi)]Cl2 complex were obtained with TD-DFT/B3LYP methodology to contribute to the assignment of electronic transition. A micellar system (F-127/Ru) produced with Pluronic F-127 copolymer was used as a drug delivery system, due to the hydrophobicity of the complex. The F-127/Ru system showed NO release in aqueous media. The free complex showed higher cytotoxicity than the F-127/Ru system in the studied tumor cells. However, the F-127/Ru system showed a higher selectivity index for lung cells. This shows that the Pluronic F-127 carrier can be a good alternative in the use of hydrophobic nitrosyl ruthenium compounds in the treatment of some types of cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
